Frailty increases vulnerability to infections, delirium, falls, hospitalizations, and dementia, and is tied to reduced biological reserves and resilience.

The overall message emphasizes that proactive midlife lifestyle changes and evolving biomedical interventions can delay or reverse frailty and extend healthy aging.

Frailty is a complex condition that begins earlier in life than commonly thought, with a pre-frailty stage appearing in people in their 30s and 40s.

Walking speed serves as a highly informative marker of frailty because it reflects the integration of multiple bodily systems.

Clinical trials are underway to test therapeutics in older and pre-frail individuals to evaluate effects on frailty markers, resilience, and surgical outcomes.

Diet, especially fiber and Mediterranean patterns, improves gut microbiome diversity and lowers frailty risk, while deficiencies in calcium, magnesium, selenium, and zinc raise risk.

Digital tools can track cumulative physiological deficits, enabling earlier identification and intervention.

Mitochondrial dysfunction and metabolic changes differentiate frail individuals, impacting energy production and organ health.

Gut microbiome diversity and inflammaging are central to frailty, affecting muscle mass, immune function, and overall aging.

Psychological state and social factors, such as loneliness and attitudes toward aging, can serve as early red flags for frailty.

The Fried model defines five predictive traits—unintentional weight loss, exhaustion, low physical activity, slow walking speed, and weak grip strength—with pre-frailty and frailty classified by the number of traits.

Interventions include resistance training, vaccination, reduced alcohol intake, and targeted dietary changes; emerging strategies explore gut microbiome modulation and anti-aging therapies such as senolytics, metformin, fisetin, spermidine, and nicotinamide riboside.